School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Obes Surg. 2020 Jun;30(6):2285-2293. doi: 10.1007/s11695-020-04463-x.
For bariatric surgery, patient selection, procedural choice and availability has changed over time internationally. We analysed the annual volume and location of bariatric surgery in New Zealand by demographic characteristics, clinical history and procedure.
Patients who underwent bariatric procedures between 1 January 2004 and 31 December 2017 were identified through New Zealand hospitalisation records. Hospitalisation and medication data were used to indicate a clinical history of cardiovascular disease (CVD) and/or diabetes. Publicly funded intervention rate by ethnicity was calculated using year- and sex-specific ethnic population estimates and obesity prevalence statistics.
This study included 9109 patients, undergoing gastric bypass (GB, n = 3323) and sleeve gastrectomy (SG, n = 5452) as the most common procedures. Nationally, annual bariatric surgery volume increased in the public sector, from 34 to 516 between 2004 and 2017, with a similar increase in available private sector figures. Public recipients were significantly more likely to have a history of diabetes (33.8% vs 14.4%) and/or CVD (9.0% vs 4.7%) than private recipients. Male recipients had higher prevalence of diabetes (29.9% vs 17.6%) and CVD (12.9% vs 4.1%) than female recipients. After adjustment for the adult population prevalence of morbid obesity, Pacific people had half the intervention rate of European and Māori.
Bariatric surgery is increasing in frequency in New Zealand, with SG and GB being the most common procedures. Significant differences in patient characteristics exist between the public and private sectors. Ensuring equitable selection of publicly funded bariatric surgery candidates remains a challenge.
在国际上,随着时间的推移,减重手术的患者选择、手术方式选择和可及性发生了变化。我们分析了新西兰按人口统计学特征、临床病史和手术对每年减重手术的数量和地点。
通过新西兰住院记录确定了 2004 年 1 月 1 日至 2017 年 12 月 31 日期间接受减重手术的患者。住院和药物治疗数据用于表示心血管疾病(CVD)和/或糖尿病的临床病史。通过使用特定年份和性别的种族人口估计数和肥胖流行统计数据,计算了按种族划分的公共资助干预率。
本研究共纳入 9109 例患者,行胃旁路术(GB,n=3323)和袖状胃切除术(SG,n=5452)的患者最多。在全国范围内,公共部门的年度减重手术量从 2004 年的 34 例增加到 2017 年的 516 例,私人部门的数字也有类似的增加。与私人部门相比,公共部门的接受者更有可能有糖尿病(33.8%比 14.4%)和/或 CVD(9.0%比 4.7%)的病史。男性接受者的糖尿病(29.9%比 17.6%)和 CVD(12.9%比 4.1%)患病率高于女性接受者。在调整了病态肥胖的成年人口患病率后,太平洋地区居民接受手术的比例是欧洲和毛利人的一半。
新西兰的减重手术频率在增加,SG 和 GB 是最常见的手术方式。公共和私人部门的患者特征存在显著差异。确保公平选择公共资助的减重手术候选者仍然是一个挑战。